Prospective, double-blind, randomized controlled trial on efficacy of lidocaine injection method during esophageal endoscopic submucosal dissection.

Prospective, double-blind, randomized controlled trial on efficacy of lidocaine injection method during esophageal endoscopic submucosal dissection. - LIM study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032804

Enrollment

Registered

2018-06-01

Start date

2018-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

early esophageal cancer

Interventions

Esophageal ESD with lidocaine injection Esophageal ESD without lidocaine injection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients performed ESD for esophageal cancer

Exclusion criteria

Exclusion criteria: General anesthetic management Lidocaine allergy Patients with severe systemic disease(>ASA4) Patients without informed consent Patients already enrolled in the same study Considered by a study physician to be inappropriate for any other reason

Design outcomes

Primary

Measure	Time frame
body movement during ESD	—

Secondary

Measure	Time frame
Treatment time Dose of midazolam Postoperative pain Complication (bleeding, perforation, Aspiration pneumonia, Hypoxemia, bradycardia, hypotension)	—

Countries

Japan

Contacts

Public ContactTetsuya Yoshizaki

Saiseikai Nakatsu Hospital gastroenterology

yoshizak@med.kobe-u.ac.jp06-6372-0333

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026